Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Dun And Bradstreet Holding Inc is a financial data & stock exchanges business based in the US. Dun And Bradstreet Holding Inc shares (DNB) are listed on the NYSE and all prices are listed in US Dollars. Dun And Bradstreet Holding Inc employs 6,296 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $15.10 |
|---|---|
| 52-week range | $13.67 - $21.88 |
| 50-day moving average | $15.78 |
| 200-day moving average | $17.86 |
| Wall St. target price | $20.27 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.18 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $15.1 from 2022-07-01
| 1 week (2022-06-28) | 0.07% |
|---|---|
| 1 month (2022-06-03) | -8.21% |
| 3 months (2022-04-05) | -12.92% |
| 6 months (2022-01-05) | -24.27% |
| 1 year (2021-07-02) | -30.83% |
|---|---|
| 2 years (2020-07-02) | -44.28% |
| 3 years (2019-07-01) | N/A |
| 5 years (2017-07-01) | N/A |
Valuing Dun And Bradstreet Holding Inc stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Dun And Bradstreet Holding Inc's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Dun And Bradstreet Holding Inc's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.86. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Dun And Bradstreet Holding Inc's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Dun And Bradstreet Holding Inc's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $726.4 million.
The EBITDA is a measure of a Dun And Bradstreet Holding Inc's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.2 billion |
|---|---|
| Operating margin TTM | 10.46% |
| Gross profit TTM | $1.5 billion |
| Return on assets TTM | 1.45% |
| Return on equity TTM | -1.96% |
| Profit margin | -3.55% |
| Book value | $8.39 |
| Market capitalisation | $6.6 billion |
TTM: trailing 12 months
We're not expecting Dun And Bradstreet Holding Inc to pay a dividend over the next 12 months.
Over the last 12 months, Dun And Bradstreet Holding Inc's shares have ranged in value from as little as $13.67 up to $21.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Dun And Bradstreet Holding Inc's is 0.7357. This would suggest that Dun And Bradstreet Holding Inc's shares are less volatile than average (for this exchange).
Dun & Bradstreet Holdings, Inc. provides business decisioning data and analytics in North America and internationally. It offers finance and risk solutions, including D&B Finance Analytics, an online application that offers clients real time access to its information, comprehensive monitoring, and portfolio analysis; D&B Direct, an application programming interface (API) that delivers risk and financial data directly into enterprise applications for real-time credit decision making; D&B Small Business, a suite of powerful tools that allows SMBs to monitor and build their business credit file; D&B Enterprise Risk Assessment Manager, a solution for managing and automating credit decisioning and reporting; and InfoTorg, an online SaaS application. The company also provides risk and compliance solutions, such as D&B Supplier Risk Manager that provides insights to help certify, monitor, analyze, and mitigate risk across the supply chain; D&B Onboard to provide comprehensive insights into businesses to facilitate KYC/AML compliance, as well as to minimize financial, legal, and reputational risk exposure; and D&B Beneficial Ownership that offers risk intelligence on ultimate beneficial ownership. It offers sales and marketing solutions, including D&B Connect, a self-service data management platform; D&B Optimizer, an integrated data management solution; D&B Rev. Up ABX, an open and agnostic platform that aligns marketing and sales teams to deliver an optimal and coordinated buying; D&B Hoovers, a sales intelligence solution; D&B Audience Targeting, which helps clients to reach the right audiences with the right messages; D&B Visitor Intelligence that turns web visitors into leads; and D&B Direct, an API-enabled data management solution that delivers valuable customer insights into CRMs, marketing automation, and other marketing applications for on-demand business intelligence. The company was founded in 1841 and is headquartered in Jacksonville, Florida.
Everything we know about the Citrine Global IPO, plus information on how to buy in.
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.